Home » Newsletters » BioWorld Asia

BioWorld Asia

July 5, 2000

View Archived Issues

Modex Raises US$103M In IPO In Switzerland To Fund Programs

Pharmagene Plans To Go Public In London, Says Time Is Right

Research Shows Strategies For Malaria Could Be Off Target

Mologen Raises EUR12.45M For Phase III Cancer Trials

European Stem Cell Debate Provokes Deeper Questions

Metris Raises #11M Privately For Work On Women's Health

Transghne, IntroGene Collaborate To Produce Adenoviral Vectors

Molecular Engine Formed To Exploit Novel Cancer Approach

IDM Issued U.S. Patent Covering Cell Preparation

Other News To Note

Oxford BioMedica Demonstrates Utility Of LentiVector Technology

Memorec Seeks Up To US$15M For Integrated Genomics Work

Australian Consortium Awarded $16M By NIH For AIDS Vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.